Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

RGH-896 demonstrates in vivo analgesia

Sep. 28, 2004

New perspectives in the use of sumatriptan to treat migraine

Sep. 28, 2004

Merck KGaA grants vilazodone rights to Genaissance

Sep. 28, 2004

Novartis presents new cathepsin S inhibitors with utility in neuropathic pain

Sep. 28, 2004

AF-3191 effective in preclinical pain models

Sep. 27, 2004

GW-274150 reduces experimental neuropathic hypersensitivity

Sep. 27, 2004

In vivo effects of capsaicin reduced by GW-833972

Sep. 27, 2004

Clinical evidence for the efficacy of topiramate in the prevention of migraine

Sep. 27, 2004

Ceregene begins phase I trial of novel gene therapy for Alzheimer's disease

Sep. 27, 2004

Insight into mechanism of action of analgesic GR-242468

Sep. 23, 2004

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...